Home Infusion Therapy Market Size, Share & Trends Report

Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Feb, 2021
  • Base Year for Estimate: 2020
  • Report ID: 978-1-68038-389-8
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 100

Report Overview

The global home infusion therapy market size was valued at USD 18.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2021 to 2028. Home infusion therapy refers to the process in which patients receive treatment at home through the administration of drugs or biological products through catheters and needles. Receiving treatment at home as opposed to hospitals or healthcare facilities is a cost-effective and more convenient option for patients, further driving the need for home infusion therapy. The key factors driving the market include the increasing geriatric population with decreased mobility profile, rising preference for home care, and rapid technological advancements. Several conditions such as immune deficiencies, cancer, and congestive heart failure require infusion therapy as these conditions cannot be treated with oral medication. Since these patients require long-term treatment, home infusion therapy is considered a more cost-effective alternative to receiving treatment in hospitals.

Global home infusion therapy market size, by product, 2016 - 2028 (USD Million)

While administering medication to patients, glutamine, phospholipids, and glucose are also added to the infusion for providing added nutrition, which is another important benefit of infusion therapy. Technological developments in these devices significantly contribute to making home infusion therapy more convenient and user-friendly for patients. For instance, smart pumps are increasingly adopted as these pumps contain advanced features. These pumps help provide an accurate and controlled rate of infusion, which is particularly beneficial for chemotherapy.

On the basis of application, chemotherapy is projected to be the fastest-growing segment over the forecast period. According to the WHO, 19.3 million new cases of cancer were reported globally in 2020. The high prevalence of cancer is anticipated to positively impact the growth of the chemotherapy market. Thus, the increasing popularity of home-based therapy for cancer owing to the associated benefits, such as cost-effectiveness, is anticipated to drive the market.

COVID19 impact: 14.0% increase in demand

Pandemic Impact

Post COVID Outlook

During the pandemic, emergency room visits were down by half or more, and admissions that are not related to COVID-19 also followed a similar or even more accelerated decline.

Covid-19 uncovered the importance and effectiveness of in-house treatment & home infusion for diseases like cancer, diabetes, and cardiology

The pandemic has resulted in a lower rate of emergency room utilization & hospitalizations, which led to demand for in-home medicine delivery settings

The Cancer Care at Home program has made an addition of 12 chemotherapeutics, which formerly were not often provided through home infusion. Out of 670 patients enrolled in the program, 301 have been referred for home infusion, which is a 46% increase in the number of patients previously receiving in-house cancer treatment

Smiths Medical stated that demand for infusion pumps increased substantially. The company’s revenue from infusion system was up by 4%, driven by COVID-19 related demand

In April 2020, FDA relaxed rules for infusion pumps & their accessories and stated that it will not object to companies making certain modifications to already cleared infusion pumps, which has a positive impact on the overall market


The COVID-19 pandemic led to a spike in the hospitalization of several people and often many were to be placed on ventilators. This occupied space in hospitals as the infected patients are to be placed where they will not contaminate other patients and the healthcare professionals. Due to the increasing need for space and beds in hospitals, companies are focusing to transition patients from the hospital to in-home, creating demand for home infusion therapy. In February 2020, the Cancer Care at Home program was launched by the Penn Center for Cancer Care Innovation at the University of Pennsylvania’s Abramson Cancer Center. Its aim was to broaden the delivery of oncology treatments to patients in the home setting. From mid-March to late-April, the company reported a 700% increase in the number of patients participating in the program. This highlights the bright future that lies ahead for the home infusion market in the years to come.

Product Insights

The infusion pumps segment accounted for the largest share of 50.5% in 2020 as these pumps are widely preferred for the delivery of nutrients and medications. The availability of a variety of products, such as an enteral, syringe, multichannel, and peristaltic pumps, further contributes to the segment growth. The rising demand for syringes and ambulatory pumps owing to increasing preference for home healthcare is also anticipated to contribute to the segment growth.  On the basis of product, the market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors.

Nowadays, smart pumps are widely used as these pumps contain advanced features, such as barcode technology, which helps in the verification of a patient’s identity and also helps prevent drug administration errors. Needleless connectors are anticipated to register the highest CAGR over the forecast period. These connectors offer improved safety, enable smooth surgeries, and help adhere to good clinical practice (GCP), which contributes to the growth of the segment.

Application Insights

The anti-infective application segment dominated the market for home infusion therapy in 2020 with a share of 27.1%. This is attributed to the considerable number of procedures performed for the administration of antifungal and antibiotic drugs. It also helps reduce exposure to patients with other hospital-acquired infections (HAIs). On the basis of application, the market has been segmented into anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others.

Global home infusion therapy market share, by application, 2020 (%)

Chemotherapy is estimated to be the fastest-growing segment over the forecast period. With the growing incidences of cancer, the demand for pressure pumps is expected to increase in the coming years. Pumps used for chemotherapy at home are compact, continuous pressure pumps, which do not require a battery and can hence be used for a longer period of time. With the help of these pumps, chemotherapy drugs can be administered at the appropriate infusion speed and in the right amounts.

Regional Insights

North America dominated the market for home infusion therapy in 2020 with a share of 57.1% and this trend is expected to continue throughout the forecast period. This can be attributed to increasing R&D in the region and the rising adoption of new technology in infusion pumps. The increasing need for long-term therapy for patients with certain conditions is driving the regional market. Development of alternate healthcare settings and home infusion services and shifting preference from acute care to home care settings due to low cost and enhanced patient mobility are likely to boost the growth of this market in the coming years.

The Asia Pacific market is expected to expand at a significant CAGR of 10.4% over the forecast period. This is attributed to rising patient awareness regarding the benefits of home infusion therapy over in-hospital procedures and the growing prevalence of diabetes in the region.

Key Companies & Market Share Insights

The global market is highly competitive. One of the key factors driving competitiveness among market players is the rapid adoption of advanced healthcare technology for improved healthcare services. Moreover, major players often adopt strategies, such as mergers, acquisitions, and new product launches, to retain market share and diversify their product portfolio. For instance, B. Braun launched Easypump, a home infusion therapy app for healthcare professionals as well as patients. This app helps patients safely administer medication by providing instructions on how to properly manage and use the pump. Some prominent players in the global home infusion therapy market include:

  • CVS/Coram

  • Option Care Health

  • BriovaRx/Diplomat (UnitedHealth Optum)

  • PharMerica

  • Fresenius Kabi

  • ICU Medical, Inc.

  • B. Braun Melsungen AG

  • Baxter

  • BD

  • Caesarea Medical Electronics

  • Smiths Medical

  • Terumo Corporation

  • JMS Co. Ltd.

Home Infusion Therapy Market Report Scope

Report Attribute


Market size value in 2021

USD 25.3 billion

Revenue forecast in 2028

USD 44.7 billion

Growth Rate

CAGR of 8.5% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Netherlands; Belgium; Switzerland; Russia; Sweden; China; India; Japan; Australia; South Korea; Malaysia; Indonesia; Singapore; Philippines; Thailand; Mexico; Brazil; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Israel; Egypt

Key companies profiled

CVS/Coram; Option Care Health; BriovaRx/Diplomat (UnitedHealth Optum); PharMerica; Fresenius Kabi; ICU Medical, Inc.; B. Braun Melsungen AG; Baxter; BD; Caesarea Medical Electronics; Smiths Medical; Terumo Corporation; JMS Co. Ltd.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global home infusion therapy market report on the basis of product, application, and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Infusion Pumps

      • Elastomeric

      • Electromechanical

      • Gravity

      • Others

    • Intravenous Sets

    • IV Cannulas

    • Needleless Connectors      

  • Application Outlook (Revenue, USD Million, 2016 - 2028)

    • Anti-infective

    • Endocrinology

      • Diabetes

      • Others

    • Hydration Therapy

      • Athletes

      • Others

    • Chemotherapy

    • Enteral Nutrition

    • Parenteral Nutrition

    • Specialty Pharmaceuticals

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Spain

      • Italy

      • Netherlands

      • Belgium

      • Switzerland

      • Russia

      • Sweden

    • Asia Pacific

      • India

      • Japan

      • China

      • Australia

      • South Korea

      • Malaysia

      • Indonesia

      • Singapore

      • Philippines

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

      • Chile

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Israel

      • Egypt

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.